← Back to Screener
DarioHealth Corp. Common Stock (DRIO)
Price$7.46
Favorite Metrics
Price vs S&P 500 (26W)-58.13%
Price vs S&P 500 (4W)-8.67%
Market Capitalization$54.46M
All Metrics
Book Value / Share (Quarterly)$11.07
P/TBV (Annual)0.50x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)9.65%
Cash Flow / Share (Quarterly)$-3.98
Price vs S&P 500 (YTD)-38.19%
Gross Margin (TTM)56.86%
Net Profit Margin (TTM)-171.09%
EPS (TTM)$-14.91
10-Day Avg Trading Volume0.02M
EPS Excl Extra (TTM)$-14.91
Revenue Growth (5Y)29.03%
EPS (Annual)$-17.43
ROI (Annual)-42.35%
Gross Margin (Annual)49.06%
Net Profit Margin (5Y Avg)-287.54%
Cash / Share (Quarterly)$4.71
Revenue Growth QoQ (YoY)-32.55%
ROA (Last FY)-35.96%
Revenue Growth TTM (YoY)7.29%
EBITD / Share (TTM)$-13.67
ROE (5Y Avg)-86.70%
Operating Margin (TTM)-183.54%
Cash Flow / Share (Annual)$-20.16
P/B Ratio0.73x
P/B Ratio (Quarterly)0.82x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)2.15x
Net Interest Coverage (TTM)-564.36x
ROA (TTM)-36.75%
EPS Incl Extra (Annual)$-17.43
Current Ratio (Annual)2.44x
Quick Ratio (Quarterly)4.02x
3-Month Avg Trading Volume0.02M
52-Week Price Return-46.71%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$8.65
P/S Ratio (Annual)2.01x
Asset Turnover (Annual)0.23x
52-Week High$17.74
Operating Margin (5Y Avg)-303.71%
EPS Excl Extra (Annual)$-17.43
CapEx CAGR (5Y)6.65%
Tangible BV CAGR (5Y)48.48%
26-Week Price Return-51.24%
Quick Ratio (Annual)2.04x
13-Week Price Return-36.99%
Total Debt / Equity (Annual)0.40x
Current Ratio (Quarterly)4.55x
Enterprise Value$53.171
Revenue / Share Growth (5Y)27.06%
Asset Turnover (TTM)0.21x
Book Value / Share Growth (5Y)34.29%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)2.81x
Pretax Margin (Annual)-164.94%
Cash / Share (Annual)$14.92
3-Month Return Std Dev76.74%
Gross Margin (5Y Avg)33.16%
Net Income / Employee (TTM)$-0
ROE (Last FY)-59.36%
Net Interest Coverage (Annual)-9.15x
EPS Basic Excl Extra (Annual)$-17.43
Receivables Turnover (TTM)6.51x
Total Debt / Equity (Quarterly)0.41x
EPS Incl Extra (TTM)$-14.91
Receivables Turnover (Annual)6.58x
ROI (TTM)-41.91%
P/S Ratio (TTM)2.20x
Pretax Margin (5Y Avg)-288.82%
Revenue / Share (Annual)$11.03
Tangible BV / Share (Annual)$27.75
Price vs S&P 500 (52W)-81.35%
Year-to-Date Return-34.45%
5-Day Price Return-1.32%
EPS Normalized (Annual)$-17.43
ROA (5Y Avg)-61.82%
Net Profit Margin (Annual)-158.09%
Month-to-Date Return-6.98%
Cash Flow / Share (TTM)$-2.02
EBITD / Share (Annual)$-18.10
Operating Margin (Annual)-229.47%
LT Debt / Equity (Annual)0.33x
ROI (5Y Avg)-72.66%
LT Debt / Equity (Quarterly)0.41x
EPS Basic Excl Extra (TTM)$-14.91
P/TBV (Quarterly)1.05x
P/B Ratio (Annual)0.37x
Inventory Turnover (TTM)2.22x
Pretax Margin (TTM)-170.38%
Book Value / Share (Annual)$37.52
Price vs S&P 500 (13W)-39.37%
Beta1.10x
Revenue / Share (TTM)$7.88
ROE (TTM)-59.47%
52-Week Low$5.93
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.10
4.10
4.10
4.09
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
DRIODarioHealth Corp. Common Stock | 2.20x | 29.03% | 56.86% | -183.54% | $7.46 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
DarioHealth Corp is a digital therapeutics company that delivers personalized interventions for chronic conditions including diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The platform combines data analytics, software, and personalized coaching to drive patient engagement and clinical outcomes.